we believe this is the most exciting time in history to be involved in healthcare. our team is leading transformative change; rapidly evolving the system from “sick care” to “well care.” we think life’s too short not to do something with passion, and here at privia we’re doing something that makes a tangible difference. we look for people with that passion. people who want to experience life to the fullest. people who are curious, resourceful, hard working, and tenacious. people who disdain the status quo. our culture is made up of people who look at the world and see opportunity, and who aren’t afraid to dive right in, experience life, and make that opportunity happen.
Company profile
Ticker
PRVA
Exchange
Website
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
PH Group Parent Corp.
SEC CIK
Corporate docs
Subsidiaries
BASS Privia Management Company • CMG ACO, LLC • Complete MD Solutions, LLC • Patient Health Advocacy Solutions, LLC • PH Group Holdings Corp. • PMG POL, LLC • PMG South Carolina Holdings • PMG Washington Holdings • PMG West Texas Holdings • PQN Central Texas, LLC ...
PRVA stock data
Latest filings (excl ownership)
ARS
2023 FY
Annual report to shareholders
4 Apr 24
DEFA14A
Additional proxy soliciting materials
4 Apr 24
DEF 14A
Definitive proxy
4 Apr 24
PRE 14A
Preliminary proxy
21 Mar 24
10-K
2023 FY
Annual report
27 Feb 24
8-K
Privia Health Reports Fourth Quarter and Full-Year 2023 Financial Results
27 Feb 24
8-K
Privia Health Appoints Edward C. Fargis as General Counsel
29 Jan 24
8-K
Regulation FD Disclosure
8 Jan 24
8-K
Entry into a Material Definitive Agreement
21 Nov 23
10-Q
2023 Q3
Quarterly report
3 Nov 23
Transcripts
PRVA
Earnings call transcript
2023 Q4
27 Feb 24
PRVA
Earnings call transcript
2023 Q3
3 Nov 23
PRVA
Earnings call transcript
2023 Q2
3 Aug 23
PRVA
Earnings call transcript
2023 Q1
4 May 23
PRVA
Earnings call transcript
2023 Q1
4 May 23
PRVA
Earnings call transcript
2022 Q4
28 Feb 23
PRVA
Earnings call transcript
2022 Q3
13 Nov 22
PRVA
Earnings call transcript
2022 Q2
11 Aug 22
PRVA
Earnings call transcript
2022 Q1
14 May 22
PRVA
Earnings call transcript
2021 Q4
25 Mar 22
Latest ownership filings
4
David Mountcastle
4 Apr 24
144
Notice of proposed sale of securities
2 Apr 24
4
David Mountcastle
15 Mar 24
4
Parth Mehrotra
15 Mar 24
4
Edward C Fargis
15 Mar 24
4
William M Sullivan
12 Mar 24
144
Notice of proposed sale of securities
8 Mar 24
SC 13G
VANGUARD GROUP INC
13 Feb 24
SC 13G/A
GOLDMAN SACHS GROUP INC
13 Feb 24
SC 13G/A
FMR LLC
9 Feb 24
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | |
---|---|---|---|
Revenue | |||
Cost of revenue | |||
Operating income | |||
Operating margin | |||
Net income | |||
Net profit margin | |||
Cash on hand | |||
Change in cash | |||
Diluted EPS |
Institutional ownership, Q3 2023
97.5% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 220 |
Opened positions | 30 |
Closed positions | 45 |
Increased positions | 89 |
Reduced positions | 70 |
13F shares | Current |
---|---|
Total value | 2.50 tn |
Total shares | 115.69 mm |
Total puts | 44.50 k |
Total calls | 178.60 k |
Total put/call ratio | 0.2 |
Largest owners | Shares | Value |
---|---|---|
BLK Blackrock | 16.43 mm | $377.81 bn |
FMR | 14.27 mm | $328.25 bn |
Vanguard | 11.00 mm | $253.09 bn |
Durable Capital Partners | 9.09 mm | $209.09 bn |
William M Sullivan | 5.85 mm | $0.00 |
T. Rowe Price Investment Management | 4.73 mm | $108.67 bn |
Wellington Management | 4.66 mm | $107.10 bn |
BK Bank Of New York Mellon | 4.04 mm | $92.92 bn |
Riverbridge Partners | 3.99 mm | $91.85 bn |
PFG Principal Financial Group Inc - Registered Shares | 3.51 mm | $80.62 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
2 Apr 24 | David Mountcastle | Common Stock, par value $0.01 per share | Sell | Dispose S | No | No | 17.77 | 3,933 | 69.89 k | 262,279 |
11 Mar 24 | William M Sullivan | Common Stock, $0.01 par value per share | Sell | Dispose S | Yes | Yes | 23.02 | 400 | 9.21 k | 5,445,018 |
8 Mar 24 | William M Sullivan | Common Stock, $0.01 par value per share | Sell | Dispose S | Yes | Yes | 23.03 | 7,115 | 163.86 k | 5,445,418 |
8 Mar 24 | Parth Mehrotra | Common Stock, $0.01 par value per share | Grant | Acquire A | No | No | 0 | 119,885 | 0.00 | 273,859 |
8 Mar 24 | David Mountcastle | Common Stock, par value $0.01 per share | Grant | Acquire A | No | No | 0 | 38,058 | 0.00 | 210,596 |
8 Mar 24 | Edward C Fargis | Common Stock, $0.01 par value per share | Grant | Acquire A | No | No | 0 | 28,544 | 0.00 | 72,948 |
News
Analyst Scoreboard: 8 Ratings For Privia Health Gr
19 Mar 24
Canaccord Genuity Maintains Buy on Privia Health Gr, Lowers Price Target to $37
19 Mar 24
JP Morgan Maintains Overweight Rating for Privia Health Gr: Here's What You Need To Know
6 Mar 24
Barclays Initiates Coverage On Privia Health Gr with Equal-Weight Rating, Announces Price Target of $22
6 Mar 24
UBS Maintains Buy on Privia Health Gr, Lowers Price Target to $29
1 Mar 24